These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation of Altered Drug Pharmacokinetics in Critically Ill Adults Receiving Extracorporeal Membrane Oxygenation. Ha MA; Sieg AC Pharmacotherapy; 2017 Feb; 37(2):221-235. PubMed ID: 27931091 [TBL] [Abstract][Full Text] [Related]
3. The challenges of multiple organ dysfunction syndrome and extra-corporeal circuits for drug delivery in critically ill patients. Hites M; Dell'Anna AM; Scolletta S; Taccone FS Adv Drug Deliv Rev; 2014 Nov; 77():12-21. PubMed ID: 24842474 [TBL] [Abstract][Full Text] [Related]
4. Pharmacotherapy during pediatric extracorporeal membrane oxygenation: a review. Himebauch AS; Kilbaugh TJ; Zuppa AF Expert Opin Drug Metab Toxicol; 2016 Oct; 12(10):1133-42. PubMed ID: 27322360 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics in critically ill patients. Varghese JM; Roberts JA; Lipman J Curr Opin Anaesthesiol; 2010 Aug; 23(4):472-8. PubMed ID: 20489605 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients. Hahn J; Choi JH; Chang MJ J Clin Pharm Ther; 2017 Dec; 42(6):661-671. PubMed ID: 28948652 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic/pharmacodynamic considerations for the optimization of antimicrobial delivery in the critically ill. Tsai D; Lipman J; Roberts JA Curr Opin Crit Care; 2015 Oct; 21(5):412-20. PubMed ID: 26348420 [TBL] [Abstract][Full Text] [Related]
8. Drug absorption, distribution, metabolism and excretion considerations in critically ill adults. Roberts DJ; Hall RI Expert Opin Drug Metab Toxicol; 2013 Sep; 9(9):1067-84. PubMed ID: 23682923 [TBL] [Abstract][Full Text] [Related]
9. Altered pharmacology in the Intensive Care Unit patient. Zagli G; Tarantini F; Bonizzoli M; Di Filippo A; Peris A; De Gaudio AR; Geppetti P Fundam Clin Pharmacol; 2008 Oct; 22(5):493-501. PubMed ID: 18684127 [TBL] [Abstract][Full Text] [Related]
10. The impact of continuous renal replacement therapy on drug therapy. Susla GM Clin Pharmacol Ther; 2009 Nov; 86(5):562-5. PubMed ID: 19727069 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics in the critically ill patient. Park GR Xenobiotica; 1993 Nov; 23(11):1195-230. PubMed ID: 8310706 [TBL] [Abstract][Full Text] [Related]
12. Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practice. Johnson TN; Rostami-Hodjegan A Paediatr Anaesth; 2011 Mar; 21(3):291-301. PubMed ID: 20497354 [TBL] [Abstract][Full Text] [Related]
13. Influence of renal replacement therapy on pharmacokinetics in critically ill patients. Bugge JF Best Pract Res Clin Anaesthesiol; 2004 Mar; 18(1):175-87. PubMed ID: 14760881 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of Commonly Used Antimicrobials in Critically Ill Adults During Extracorporeal Membrane Oxygenation: A Systematic Review. Duceppe MA; Kanji S; Do AT; Ruo N; Cavayas YA; Albert M; Robert-Halabi M; Zavalkoff S; Dupont P; Samoukovic G; Williamson DR Drugs; 2021 Jul; 81(11):1307-1329. PubMed ID: 34224115 [TBL] [Abstract][Full Text] [Related]
15. From Multiple Organ Support Therapy to Extracorporeal Organ Support in Critically Ill Patients. Ronco C; Ricci Z; Husain-Syed F Blood Purif; 2019; 48(2):99-105. PubMed ID: 31030203 [TBL] [Abstract][Full Text] [Related]